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Abstract
Background: Bacterial infections are very common in End Stage Renal Disease (ESRD) patients. The diagnosis of
sepsis in such patients is often challenging and requires a high index of suspicion. The aim of this study is to report
on a series of patient with ESRD on hemodialysis (HD) diagnosed with sepsis.
Methods: Single center retrospective study looking at ESRD on HD who presented to our tertiary hospital
were retrieved. Inclusion criteria included a discharge diagnosis of sepsis, septic shock or bacteremia.
Results: Our sample was composed of 41 females and 49 males, with a mean age of 70 ± 15 years. Infections
from the HD catheters followed by lower respiratory tract infections were the most common cause of bacteremia. IV
fluid replacement for the first 6 and 24 h were 0.58 and 1.27 l respectively. Vasopressors were used in 30 patients with
norepinephrine, dopamine and dobutamine used in 22, nine and one patients respectively. Out of 90 subjects, 24
(26.6 %) were dead within the same hospital visit. the 28 days out of hospital mortality was 25.6 %. There was no
significant difference in mortality in patients who presented with less than two SIRS or two or more SIRS criteria.
Conclusion: This is the first study looking at an in depth analysis of sepsis in the specific dialysis population and
examining the influence of fluid resuscitation, role of SIRS criteria and vasopressor use on their mortality.
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Background
Sepsis ranks as the 10th leading cause of death in the
United States. Rivers et Al. showed that early identifica-
tion of sepsis and implementation of Early Goal Directed
Therapy (EGDT) have been shown to improve out-
comes and decrease mortality in patients with severe
sepsis and septic shock [1]. Consequently, hospitals
have implemented protocols and sepsis bundles in
order to decrease its associated mortality and morbidity
[2, 3]. Sepsis and bacterial infections are very common
in End Stage Renal Disease (ESRD) patients [4–6] and
following cardiovascular disease; infection is the second
leading cause of death in patients with ESRD [6, 7].
Emergency Physicians are often faced with the hypotensive,
weak ESRD patient presenting from dialysis and are usually
anchored on the diagnosis of hypovolemia. The diagnosis
of sepsis in such patients is often challenging and requires
a high index of suspicion. Most studies on sepsis, ranging
from the sensitivity of the systematic inflammatory re-
sponse syndrome (SIRS) criteria [8] to lactate clearance [9]
and optimal fluid therapy have looked at a general pa-
tient population. The aim of this study is to report on a
series of patients with ESRD on hemodialysis (HD) di-
agnosed with sepsis, and to determine whether initial
presentation, comorbidities, time to antibiotics or re-
suscitation, disposition affects hospital and 1 month
mortality.
Summary
The aim of this study is to report on a series of
hemodialysis patients admitted to the hospital with a
diagnosis of sepsis or septic shock. We looked at their
in hospital mortality, at the parameters of resuscitation
and at the value of the SIRS criteria. As such, this article
sheds light on a special subset of population and should
be of interest to nephrologists.
Methods
This was a retrospective study approved by our Institu-
tional Review Board (IRB# ER.GA.03). Patients with a
known history of ESRD on HD presenting to the Emer-
gency Department at a single university based institu-
tion within a 5-year period were retrieved. Patients
were included if the discharge diagnosis was sepsis,
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bacteremia or septic shock. Patients younger than 18 years
old, pregnant, presenting secondary to trauma or with
incomplete documentation were excluded. Age, gen-
der, ethnicity, history of diabetes, hypertension, cardiac
disease, cerebrovascular accidents, dyslipidemia, immuno-
suppression, malignancy and presence of other comorbidi-
ties were obtained from subjects’ medical record. Patients’
presentation including temperature, heart rate, respiratory
rate, oxygen saturation, blood pressure and number of
SIRS criteria were collected at initial presentation to the
Emergency Department. Site of infection, causative micro-
organism and presence of bacteremia were retrieved as
well as complete blood count, electrolytes, lactate, cardiac
enzymes and arterial blood gas results and coagulation
profile results. Time to antibiotics and amount of fluid re-
suscitation within the first 6 and 24 h, duration and type
of vasopressors and steroids administration was noted.
Disposition from the emergency department (ED), length
of stay (LOS) in the ED, intensive care unit (ICU) or gen-
eral practice unit (GPU) was calculated. Hospital mortality
was noted as well as 28-day mortality.
Statistical analyses
A two tailed sample t-test compared the difference in
mean age, LOS in ED, ICU or GPU, LOS in hospital,
time to and duration of vasopressors, antibiotics and
steroids, fluid replacement at 6 and 24 h, vital sings at
presentation and 6 h, electrolytes and blood work be-
tween deceased patients and non-deceased. Pearson’s
chi-squared test compared difference in distribution
of bacteremia, comorbidities, microbiology, disposition
from the ED, use of vasopressors or steroids, location
where antibiotics were started, number of SIRS cri-
teria at presentation between deceased subjects and
non-deceased. Statistical analyses were performed using




Our sample was composed of 41 females and 49 males,
with a mean age of 70 ± 15 years. Baseline characteristics
at presentation are listed in Table 1.
Management
Out of 90 patients, 39 were bacteremic. Infections from
the HD catheters followed by lower respiratory tract in-
fections were the most common cause of bacteremia
(Table 1). Escherichia coli followed by staphylococcus co-
agulase negative were responsible for the majority of in-
fections (Table 2).
IV fluid replacement for the first 6 and 24 h were 0.58
and 1.27 l respectively. Vasopressors and inotropes were
used in 30 patients with norepinephrine, dopamine and
dobutamine used in 22, 9 and 1 patients respectively.
Mean time to vasopressors and duration of use were
8.41 ± 7 h and 5.86 ± 7.0 days respectively. Steroids were
used in 23 patients. In 78 patients, antibiotics were initi-
ated in the ED, one in the ICU and 11 on the general
practice unit. Mean time to antibiotics administration
was 4.47 ± 7.6 h (Table 3).
Disposition
Mean length of stay in the ED, ICU and GPU was
0.58 ± 0.55, 8.88 ± 16.3 and 6.1 ± 5.2 days respectively.
24 out of 90 were admitted to the ICU unit prior to
being admitted to regular general floor. Out of 90 pa-
tients, 24 (26.6 %) died within the same hospital visit,
12 in the ICU and 12 on regular floor. There was no
death in the ED. Out of 65 discharged subjects; the
28 day out of hospital mortality was 25.6 % (Table 4).
In hospital mortality
Total in hospital mortality was 24 (26.7 %). The in hos-
pital mortality of septic shock patients was 40 %. There
was no significant difference in mean age, gender distri-
bution and comorbidities between the discharged and
deceased group. Deceased patients presented with a
higher mean heart rate (95.4 ± 25 versus 82.4 ± 15, p =
0.015), had a lower serum bicarbonate values (18.25 ± 5
versus 21.3 ± 3.5, p = 0.009) and had a significantly higher
fluid requirements within the first 24 h (2.05 ± 1.7 L versus
0.98 ± 0.98 L, p = 0.008). There was no significant differ-
ence in mortality in patients who presented with less than
two SIRS or two or more SIRS criteria. Thirty-three pa-
tients who were discharged had positive blood cultures
compared to 18 from the deceased group (p = 0.034) how-
ever there was no significant difference in microbiology
between the two groups (Table 5).
Deceased patients were more likely to be admitted to
the ICU compared to discharged patients (p = 0.003).
Patients who received norepinephrine, dopamine or
steroids had a significantly higher mortality than the
discharged subjects (p = 0.022, 0.004 and 0.008 respect-
ively) (Table 5).
Discussion
Since Early Goal Directed Therapy (EGDT) by Rivers
et al. was published there has been a steady decrease in
sepsis related mortality [2, 3]. The rate of hospitaliza-
tions due to severe sepsis however has doubled during
the past decade with estimates indicating that approxi-
mately 750,000 persons are affected annually in the USA
[10]. Although much of the therapy for severe sepsis oc-
curs in intensive care units (ICU), as many as 500,000
cases of severe sepsis are initially managed in emergency
departments (ED) annually, with an average ED length
of stay of 5 h [11–13].
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Hemodialysis patients are at risk for infections.
Using the US Renal Data System, Powe et al. aimed
to look at the incidence of infections in dialysis pa-
tients and found that during 7 years of follow-up,
11.7 % of all hemodialysis patients and 9.4 % of peri-
toneal dialysis patients had at least one episode of
septicemia [14]. To the best of our knowledge, there
is one study that looked at sepsis related mortality in
ESRD patients. Sarnak and Jaber examined dialysis
patients death registry and compared sepsis related
mortality to that of the general population and found
that sepsis mortality was 100- to 300-times higher for
chronic dialysis patients than the general public [6].
Hypothesized reasons for this association include in-
creased susceptibility to infection, the presence of co-
morbidities such as diabetes, and repetitive exposure
to pathogens during hemodialysis [15]. Our study is
unique in that it is one of the fewest studies to look
at sepsis solely in ESRD patients. We tried to look at
the in hospital mortality of sepsis in ESRD, and also
tried to look at the diagnostic value of SIRS and
Table 1 Baseline characteristics of the patients




Chronic coexisting conditions (%)a
Hypertension 83.3
Diabetes 63.3
Coronary artery disease 45.6
Dyslipidemia 31.5
Congestive heart failure 34.5
Malignancy 11.1
Chronic Obstructive lung disease or emphysema 10
Neurologic disease 7.7
Liver disease 4.5
SIRS criteria at presentation (%)
More than 2 70
Less than 2 30
Vital signs upon presentation
Temperature (°C) 37.4 ± 1.1
Systolic Blood Pressure (mm Hg) 116 ± 31.7
Diastolic Blood Pressure (mm Hg) 61.1 ± 15.5
Mean Arterial Pressure (mm Hg) 80.0 ± 19.2
Heart Rate (beats/min) 86.2 ± 19.4
Respiratory Rate (respiration/min) 21.2 ± 5.6
Oxygen Saturation (%) 96.0 ± 5.0
Base line laboratory values
White-cell count (per mm3) 14 ± 7*10000
Hemoglobin 10.9 ± 1.97
Hematocrit 32.8 ± 6.1
Lactate (mmol/liter) 29 ± 4.1
Lactate ≥4 (%) 81.3
Lactate ≤4 (%) 18.8
Creatinine (mg/dl) 5.4 ± 2.3
Blood urea nitrogen (mg/dl) 51.5 ± 24.5
Total bilirubin (mg/dl) 0.54 ± 0.6
Partial pressure of carbon dioxide (mm Hg) 35.2 ± 16.1
pH arterial blood 7.38 ± 0.01
















aValues sum to more than 100 % because patients could have more than
one condition
Table 2 Causative microorganisms
Microbiology (N, %)
E. coli 22 (24.4 %)
Staphylococcus coagulase negative 20 (22.2 %)
Klebsiella pneumonia 7 (7.8 %)
Pseudomonas aeruginosa 7 (7.8 %)
Enterococcus species 6 (6.7 %)
Staphylococcus aureus 5 (5.6 %)
Candida species 5 (5.5 %)
Proteus mirabilis 4 (4.4 %)
Serratia species 3 (3.3 %)
Acinetobacter baumani 2 (2.2 %)
Bacteroid fragilis 2 (2.2 %)
Enterobacter cloacae 2 (2.2 %)
Others 6 (6.6 %)
Clostridium species, Listeria monocytogenes, Diphteroid species,
Morganella morganii, Brucella species, Providencia alcaligenese
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lactate in this subset of population. Similar to previous
studies the most common source of infection arises from
indwelling catheters followed by lower respiratory tract in-
fections [14]. The most common organism causing sepsis
was the gram negative Escherichia Coli followed by the
skin colonizer Staphylococcus Epidermidis (Table 2).
The in hospital mortality for ESRD patients in septic
shock remains at a staggering 40 %. Septic shock is one
the leaders in mortality nowadays but with implementa-
tion of EGDT and early recognition and treatment, we
have seen an improvement in septic shock mortality
[16]. The mortality from septic shock was found to be
as high as 46 % in the original EGDT control group but
the implementation of protocols aiming at early identi-
fication and aggressive care has lead to an improved
survival and presently the mortality from septic shock
ranges between 20 and 30 [1, 16, 17]. Recent research
has shown that the most important and cornerstone of
sepsis therapy is early recognition, aggressive fluid hy-
dration and early antibiotics [18, 19].
The out of hospital 28-day mortality of any ESRD
patient admitted for sepsis remains at 25 %. ESRD
patients are predisposed to infections because of the
presence of invasive lines but are also unable to fight
invading organisms because of impaired phagocytic func-
tion [20]. This raises the issue that even after they
complete their course of antibiotics, they are still at a very
high risk of death and need very close monitoring in the
post discharge period.
Fluid resuscitation is the cornerstone of sepsis man-
agement [1, 18, 19]. The surviving sepsis campaign
recommends a 30 cc/kg bolus in the first 3 h of re-
suscitation [16]. Further fluid therapy is guided by in-
vasive hemodynamic monitoring such as the central
venous pressure. Dialysis patients often have a com-
plex presentation to the ED, while they appear fluid
overloaded on examination; they often are hypotensive
from being intravascularly depleted. Clinicians are often
anxious to aggressively hydrate dialysis patients in efforts
Table 3 Patient management characteristics
Number Mean ± SD Range
Length of Stay in EDa (Hours) 90 14.05 ± 13.188 2.00–87.75
Length of stay in ICUa (Days) 24 8.88 ± 16.346 0.04–81.00
Length of stay in GPUa (Days) 66 6.06 ± 5.179 0.13–32.88
Length of stay in the Hospital (days) 90 9.20 ± 9.981 1.04–81.08
Time to vasopressors in the first 24 h (hours) 13 8.41 ± 7.026 1.13–23.16
Time to Levophed (hours) 22 62.56 ± 85.096 1.13–315.00
Vasopressors therapy duration (days) for those who took vasopressors in the first 24 h 13 5.68 ± 6.989 0.33–22.50
Steroid Therapy duration (days) 23 14.70 ± 20.863 1.00–85.00
Time to Antibiotics treatment initiation (Hours) 89 4.47 ± 7.605 0.17–55.50
Intravenous fluids requirement first 6 h (Liters) 90 0.58 ± 0.827 0.01–5.00
Intravenous fluids requirement first 24 h (Liters) 90 1.27 ± 1.306 0.20–6.67
aED Emergency Department, ICU Intensive Care Unit, GPU General Practice Unit
Table 4 Disposition of septic ESRD patients
Number Percent
Admission
ICUa 24 26.7 %
GPUa 66 73.3 %
Hospital Mortality 24 26.7 %
Discharge Home 66 73.3 %
Mortality 28 days
Yes 23 25.6 %
Unknown 4 4.4 %
aiCU Intensive Care Unit, GPU General Practice Unit
Table 5 Effect of treatment variables on ESRD patient mortality
Mortality (No) Mortality (Yes) p-value
N % N %
Levophed 12 54.5 % 10 45.5 % 0.022
Dopamine 3 33.3 % 6 66.7 % 0.004
Steroids use 12 52.2 % 11 47.8 % 0.008
Antibiotics Initiated in EDa 55 71.4 % 22 28.6 % 0.320
Antibiotics Initiated in ICUa 0 0 % 1 100 % 0.015
Antibiotics Initiated in GPUa 10 90.9 % 1 9.1 % 0.140
SIRSa
0 or 1 20 74.1 % 7 25.9 % 0.917
≥2 46 73.0 % 17 27.0 %
Bacteremia
No 33 64.7 % 18 35.3 %
Yes 33 84.6 % 6 15.4 % 0.034
ICUa Admission 12 50.0 % 12 50.0 % 0.003
GPUa Admission 54 81.8 % 12 18.2 % 0.003
aED Emergency Department, ICU Intensive Care Unit, GPU General Practice
unit, SIRS Systemic Inflammatory Response Syndrome
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to avoid exacerbating their volume status. Such as dem-
onstrated by our study, our ESRD patients were se-
verely under resuscitated and there was a delay in
antibiotic initiation, two elements that might have con-
tributed to the elevated mortality. There is a shifting
paradigm in the treatment of sepsis currently, notably
moving away from invasive monitoring and focusing on
early aggressive hydration and antibiotics. We believe
that this also applies to ESRD patients, and emphasis
should be on these two points with intubation indicated
if there is an exacerbation of their volume status or re-
spiratory distress arises. Excess fluid can always be re-
moved by dialysis once the sepsis and bacteremia episodes
are resolved.
The SIRS criteria were proposed as a screening
method to rapidly flag possible septic patients, as sep-
sis is defined as having two or more SIRS criteria in
the setting of a presumed or documented infection.
Even though they were sensitive, SIRS criteria were
not specific and did not correlate with mortality [8].
Owing to the fact that our study was a retrospective
one, we selected patients based on their discharge
diagnosis and wanted to look at the value of the SIRS
criteria at presentation. It is interesting that in our
study, patient who presented with less than two SIRS
criteria had the same mortality as patients having two
or more criteria. Emergency physicians should there-
fore be aware of this and should maintain a high level
of suspicion when caring for ESRD patients as sepsis
can present with normal vital signs.
This is a retrospective study done in a single emer-
gency department and as such our study has many limi-
tations. Some of the patients did not have repeat vitals
at 6 h, and lactate wasn’t drawn on all patients as our
institution began measuring lactate on septic patients
fairly recently. As such, the sample size was small and
there was no control group to compare mortality and
outcomes with.
Conclusion
This is a pilot study and the aim was to look at an in
depth analysis of sepsis in the specific dialysis population
and examining the influence of fluid resuscitation, role
of SIRS criteria and vasopressor use on their mortality.
Hopefully, it will stimulate further prospective research
trials focusing on sepsis in the ESRD population.
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